-
Je něco špatně v tomto záznamu ?
Crystal structures of the complex of a kallikrein inhibitor from Bauhinia bauhinioides with trypsin and modeling of kallikrein complexes
M. Li, J. Srp, A. Gustchina, Z. Dauter, M. Mares, A. Wlodawer,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
HHSN261200800001E
National Cancer Institute
Intramural funds
National Cancer Institute
CZ.02.1.01/0.0/0.0/16_019/0000729
European Regional Development Fund, ChemBioDrug
RVO 61388963
Ústav Organické Chemie a Biochemie, Akademie Věd České Republiky
- MeSH
- Bauhinia chemie MeSH
- kalikreiny antagonisté a inhibitory chemie MeSH
- krystalografie rentgenová MeSH
- lidé MeSH
- molekulární modely MeSH
- rostlinné proteiny chemie MeSH
- skot MeSH
- trypsin chemie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- skot MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Structures of a recombinant Kunitz-type serine protease inhibitor from Bauhinia bauhinioides (BbKI) complexed with bovine trypsin were determined in two crystal forms. The crystal structure with the L55R mutant of BbKI was determined in space group P64 at 1.94 Å resolution and that with native BbKI in the monoclinic space group P21 at 3.95 Å resolution. The asymmetric unit of the latter crystals contained 44 independent complexes, thus representing one of the largest numbers of independent objects deposited in the Protein Data Bank. Additionally, the structure of the complex with native BbKI was determined at 2.0 Å resolution from P64 crystals isomorphous to those of the mutant. Since BbKI has previously been found to be a potent inhibitor of the trypsin-like plasma kallikrein, it was also tested against several tissue kallikreins. It was found that BbKI is a potent inhibitor of human tissue kallikrein 4 (KLK4) and the chymotrypsin-like human tissue kallikrein 7 (KLK7). Structures of BbKI complexed with the catalytic domain of human plasma kallikrein were modeled, as well as those with KLK4 and KLK7, and the structures were analyzed in order to identify the interactions that are responsible for inhibitory potency.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19027908
- 003
- CZ-PrNML
- 005
- 20190816093011.0
- 007
- ta
- 008
- 190813s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1107/S2059798318016492 $2 doi
- 035 __
- $a (PubMed)30644845
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Li, Mi $u Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.
- 245 10
- $a Crystal structures of the complex of a kallikrein inhibitor from Bauhinia bauhinioides with trypsin and modeling of kallikrein complexes / $c M. Li, J. Srp, A. Gustchina, Z. Dauter, M. Mares, A. Wlodawer,
- 520 9_
- $a Structures of a recombinant Kunitz-type serine protease inhibitor from Bauhinia bauhinioides (BbKI) complexed with bovine trypsin were determined in two crystal forms. The crystal structure with the L55R mutant of BbKI was determined in space group P64 at 1.94 Å resolution and that with native BbKI in the monoclinic space group P21 at 3.95 Å resolution. The asymmetric unit of the latter crystals contained 44 independent complexes, thus representing one of the largest numbers of independent objects deposited in the Protein Data Bank. Additionally, the structure of the complex with native BbKI was determined at 2.0 Å resolution from P64 crystals isomorphous to those of the mutant. Since BbKI has previously been found to be a potent inhibitor of the trypsin-like plasma kallikrein, it was also tested against several tissue kallikreins. It was found that BbKI is a potent inhibitor of human tissue kallikrein 4 (KLK4) and the chymotrypsin-like human tissue kallikrein 7 (KLK7). Structures of BbKI complexed with the catalytic domain of human plasma kallikrein were modeled, as well as those with KLK4 and KLK7, and the structures were analyzed in order to identify the interactions that are responsible for inhibitory potency.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a Bauhinia $x chemie $7 D036481
- 650 _2
- $a skot $7 D002417
- 650 _2
- $a krystalografie rentgenová $7 D018360
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kalikreiny $x antagonisté a inhibitory $x chemie $7 D007610
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a rostlinné proteiny $x chemie $7 D010940
- 650 _2
- $a trypsin $x chemie $7 D014357
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Srp, Jaroslav $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, 166 10 Prague, Czech Republic.
- 700 1_
- $a Gustchina, Alla $u Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.
- 700 1_
- $a Dauter, Zbigniew $u Synchrotron Radiation Research Section, Macromolecular Crystallography Laboratory, NCI, Argonne National Laboratory, Argonne, IL 60439, USA.
- 700 1_
- $a Mares, Michael $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, 166 10 Prague, Czech Republic.
- 700 1_
- $a Wlodawer, Alexander $u Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.
- 773 0_
- $w MED00195158 $t Acta crystallographica. Section D, Structural biology $x 2059-7983 $g Roč. 75, č. Pt 1 (2019), s. 56-69
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30644845 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190816093240 $b ABA008
- 999 __
- $a ok $b bmc $g 1433057 $s 1066368
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 75 $c Pt 1 $d 56-69 $e 20190107 $i 2059-7983 $m Acta crystallographica. Section D, Structural biology $n Acta Crystallogr D Struct Biol $x MED00195158
- GRA __
- $a HHSN261200800001E $p National Cancer Institute
- GRA __
- $a Intramural funds $p National Cancer Institute
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_019/0000729 $p European Regional Development Fund, ChemBioDrug
- GRA __
- $a RVO 61388963 $p Ústav Organické Chemie a Biochemie, Akademie Věd České Republiky
- LZP __
- $a Pubmed-20190813